SYNDESI THERAPEUTICS

Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain). Regulating synaptic transmission represents a promising approach to treating Alzheimer’s Disease and other disorders with cognitive impairment. Syndesi has an exclusive license to its platform technology from UCB, the leading company in SV2A research.

#People #Financial #Website #More

SYNDESI THERAPEUTICS

Social Links:

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2018-01-01

Address:

Louvain-la-neuve, Vlaams-Brabant, Belgium

Country:

Belgium

Website Url:

http://www.syndesitherapeutics.com

Total Employee:

11+

Status:

Closed

Contact:

Email Addresses:

[email protected]

Total Funding:

26.2 M EUR

Technology used in webpage:

SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator

Current Advisors List

morten-graugaard-døssing_image

Morten Graugaard Døssing Member Board Of Directors @ Syndesi Therapeutics
Board_member
2018-02-01

christina-takke_image

Christina Takke Member of the Board @ Syndesi Therapeutics
Board_member
2017-12-01

Current Employees Featured

jean-combalbert_image

Jean Combalbert
Jean Combalbert Non Executive Chairman @ Syndesi Therapeutics
Non Executive Chairman
2018-04-01

not_available_image

Jonathan Savidge
Jonathan Savidge CEO @ Syndesi Therapeutics
CEO
2018-02-01

torsten-m-madsen_image

Torsten M. Madsen
Torsten M. Madsen Chief Medical Officer @ Syndesi Therapeutics
Chief Medical Officer
2019-11-01

Founder

not_available_image

Jonathan Savidge

Investors List

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Syndesi Therapeutics

fountain-healthcare-partners_image

Fountain Healthcare Partners

Fountain Healthcare Partners investment in Series A - Syndesi Therapeutics

v-bio-ventures_image

V-Bio Ventures

V-Bio Ventures investment in Series A - Syndesi Therapeutics

johnson-johnson-innovation-jjdc_image

Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation – JJDC investment in Series A - Syndesi Therapeutics

ucb-ventures_image

UCB Ventures

UCB Ventures investment in Series A - Syndesi Therapeutics

s-r-i-w_image

S.R.I.W.

S.R.I.W. investment in Series A - Syndesi Therapeutics

vives-fund_image

Vives Louvain Technology Fund

Vives Louvain Technology Fund investment in Series A - Syndesi Therapeutics

w-in-g_image

W.IN.G

W.IN.G investment in Grant - Syndesi Therapeutics

vives-fund_image

Vives Louvain Technology Fund

Vives Louvain Technology Fund investment in Series A - Syndesi Therapeutics

fountain-healthcare-partners_image

Fountain Healthcare Partners

Fountain Healthcare Partners investment in Series A - Syndesi Therapeutics

Official Site Inspections

http://www.syndesitherapeutics.com

Host Informations
Whois Informations

Loading ...

More informations about "Syndesi Therapeutics" on Search Engine